Urgent

Non-invasive ventilation (NIV) in critical care

NIV · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Mask/hood inspiratory support ± EPAP for the cooperative patient: treats hypercapnic fatigue (especially COPD exacerbation with respiratory acidosis), hypoxaemia with high work of breathing, weaning, and avoids intubation in selected groups (immunosuppressed).

Red flags

  • NIV must never delay inevitable intubation — failure to improve at 1–2 h is a decision point
  • Vomiting, distension, falling GCS on NIV = stop and reassess
  • Caution in severe hypoxaemic (de novo) respiratory failure — high failure rate; low threshold for intubation

Management

  • Select: awake, cooperative, protecting airway, minimal secretions, no facial injury/vomiting
  • COPD: start IPAP ~10–12/EPAP 4–5 cmH₂O, titrate IPAP to VT, RR and pH
  • Cardiogenic pulmonary oedema: CPAP first-line; NIV if hypercapnic
  • Review at 1–2 h with a gas: pH and RR improving = continue; worse or unchanged = do not persist — intubate
  • Plan the ceiling of care BEFORE starting NIV out of hours

Exam pearls

  • Strongest evidence: COPD with pH 7.25–7.35 (Brochard NEJM 1995) and immunosuppressed patients (Antonelli)
  • A dedicated, experienced nurse at the bedside for the first hour doubles the chance of success

NIV is a monitored trial with an exit plan, not a destination.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.